Cough is a sudden and commonly repeatedly occurring voluntary or involuntary reflex to clear any foreign material from the lungs or upper respiratory tract. Frequent coughing is often a symptom for various respiratory diseases, viral and bacterial infections, chronic obstructive pulmonary diseases (COPD), allergy and cancer. Incessant coughing by a host helps the bacteria and the viruses to benefit progressively in spreading the disease to new hosts. A cough lasting for less than three weeks is an acute cough, while a cough lasting from three to eight weeks but improving by the end of that period, is a subacute cough. A consistent cough that lasts more than eight weeks is a chronic cough. When a host coughs up blood it is known as barking cough. Infections such as bronchitis or pneumonia can cause acute cough or a chronic cough. A respiratory tract infection (cold or flu) is the most common cause of a cough while smoking being the second most common cause while Asthma is the most common cause of coughing in children. Some medications rarely as a side effect cause coughing among the hosts consuming such medication. Zestril and Vasotec, common brands of Angiotensin-converting enzyme (ACE) inhibitors, commonly used to treat high blood pressure and heart conditions, often cause coughing. Though, the coughing eventually stops when the medication is discontinued. While chronic coughing is not a disease in itself, but rather a system of an underlying condition, treatment is considered in light of other consequences. Drinking lots of water, inhaling steam and using cough lozenges are also advised to treat a chronic cough. If cough is caused by bacteria, oral antibiotics are likely to be prescribed. Depending on the symptoms specific cough suppressant or cough expectorant is usually prescribed. Expectorants function by thinning mucous which causes congestion in the respiratory tract, while suppressants block body’s reflex which causes coughing. Long term prolonged use of narcotic drugs for treatment of cough may make patients habitual to these drugs.
Narcotic antitussives such as codeine, dihydrocodeine, hydrocodone, hydromorphone. Tussiden, Zutripro, Robitussin-AC, Duraganidin, Guaifenesin, Cheratussin, and Hydrostat among others are some brands prescribed for cough treatment. As narcotic drugs target the nervous system of the body and may have serious side effects, these are usually not prescribed to children. In spite of such warnings, physicians are found prescribing narcotic preparations to treat cough to children below the age of 10 years. According to an article published in CNN Health in April 2014, around eight billion prescriptions of codeine are written each year in the U.S. alone. Narcotics may cause side effects such as rashes, vomiting, constipation and allergy. The market for narcotic drugs for cough treatment is a much matured market, with a strong generic drugs base. Wide prevalence and ample supply has made the market commoditized and highly competitive. Higher prevalence of diseases and allergies due to widespread unhygienic conditions coupled with a strong market base for generics, has made India with a soaring population of 1,250 Mn, a prime focus for the market.
Prescription Narcotic Cough Preparations and Expectorants Market Key Players
Franklin Laboratories Pvt. Ltd., Glenmark Pharmaceuticals Ltd., Lyka Hetero Healthcare Limited, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pans Laboratories, Klar Sehen Pvt. Ltd., Biomedica International, Synokem Pharmaceuticals Ltd. are some of the key players in the market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.